Search
01/05/2023
Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial
Conen, D, Popova, E, Wang, MK, Chan, MTV, Landoni, G, Reimer, C, Srinathan, SK, Cata, JP, McLean, SR, Reyes, JCT, Grande, AM, Tallada, AG, Sessler, DI, Fleischmann, E, Maziak, DE, Kabon, B, Voltolini, L, Gutierrez-Soriano, L, Tandon, V, DuMerton, D, Kidane, B, Rajaram, R, Shargall, Y, Neary, JD, Wells, JR, McIntyre, WF, Blum, S, Ofori, SN, Vincent, J, Xu, LZ, Li, ZR, Healey, JS, Garg, AX, Devereaux, PJ, COP-AF Investigators. Rationale and design of the colchicine for the prevention of perioperative atrial fibrillation in patients undergoing major noncardiac thoracic surgery (COP-AF) trial. AMERICAN HEART JOURNAL. 2023; 259DOI:10.1016/j.ahj.2023.01.018. PMID:36754105. IF:3.700(Q1/3D).
27/04/2023
Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review on comparative studies
Saiz, LC, Leache, L, Gutierrez-Valencia, M, Erviti, J, Reyes, MXR. Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in hematologic malignancies: a living systematic review on comparative studies. Therapeutic Advances in Hematology. 2023; 14DOI:10.1177/20406207231168211. PMID:37138698. IF:3.400(Q2/3D).
10/04/2023
Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?
Annesi-Maesano, I, Cecchi, L, Biagioni, B, Chung, KF, Clot, B, Coen, MC, Amato, GD, Damialis, A, Dominguez-Ortega, J, Galan, C, Gilles, S, Holgate, S, Jeebhay, M, Kazadzis, S, Papadopoulos, NG, Quirce, S, Sastre, J, Tummon, F, Traidl-Hoffmann, C, Walusiak-Skorupa, J, Alonso-Coello, P, Canelo-Aybar, C, Cantero-Fortiz, Y, Rigau, D, Salazar, J, Verdugo-Paiva, F, Jutel, M, Akdis, CA, Agache, I. Is exposure to pollen a risk factor for moderate and severe asthma exacerbations?. ALLERGY. 2023; 78(8)DOI:10.1111/all.15724. PMID:36961370. IF:12.600(Q1/1D).
04/04/2023
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
Martin-Loeches, I, Torres, A, Nagavci, B, Aliberti, S, Antonelli, M, Bassetti, M, Bos, L, Chalmers, J, Derde, L, de Waele, J, Garnacho-Montero, J, Kollef, M, Luna, C, Menendez, R, Niederman, M, Ponomarev, D, Restrepo, M, Rigau, D, Schultz, M, Weiss, E, Welte, T, Wunderink, R. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. INTENSIVE CARE MEDICINE. 2023; 49(6)DOI:10.1007/s00134-023-07033-8. PMID:37012484. IF:29.600(Q1/1D).